Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
23 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adcendo-aps-to-present-data-on-its-clinical-stage-adcs-adce-t02-and-adce-d01-at-the-2025-american-association-for-cancer-research-aacr-annual-meeting-302435250.html
01 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adcendo-aps-announces-changes-in-board-of-directors-and-strengthens-executive-leadership-team-302416200.html
26 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adcendo-aps-announces-us-fda-clearance-of-ind-application-for-phase-i-tiffany-01-trial-of-adce-t02-302384298.html
25 Nov 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/novo-holdings-backed-adcendo-secures-135m-adc-pipeline
08 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adcendo-announces-us-fda-clearance-of-ind-application-for-phase-iii-first-in-human-adcelerate-01-trial-of-adce-d01-uparap-receptor-targeting-adc-trial-in-patients-with-metastatic-andor-unresectable-soft-tissue-sarcoma-sts-302268929.html
20 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adcendo-aps-and-multitude-therapeutics-inc-announce-global-development-and-commercialization-agreement-on-first-in-class-adc-drug-candidate-targeting-tissue-factor-302225429.html
ABOUT THIS PAGE